The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
From medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact Areas
Explore stories, news, insights, and data across articles, videos, and podcasts.
view all content types
students
in Israel and Europe for research on artificial intelligence
in Europe and #21 in the world for aerospace engineering*
The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Explore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATSATS is a community of supporters, innovators, and champions of possibility united by one mission: transforming Israel and the world through science and discovery.
Learn MoreFor more than 100 years, the Technion has been Israel's technological engine and leading driver of innovation, technology, and entrepreneurship, transforming ideas into impact.
Learn More
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn MoreFrom medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact AreasExplore stories, news, insights, and data across articles, videos, and podcasts.
view all content typesExplore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATS
Prof. Gepstein’s research laboratory centers on the emerging fields of cardiovascular regenerative medicine and the treatment of cardiac disorders. His lab was one of the first in the world to generate beating human heart cells from embryonic stem cells. The new heart tissue could potentially be used for the regeneration of heart muscle following a heart attack, and for the creation of genetically-engineered cell grafts to treat cardiac arrhythmias.
In early 2020, Prof. Gepstein with colleagues from Rambam and the McEwen Stem Cell Institute at the University Health Network in Toronto, used human stem cells to produce 3D engineered cardiac tissue of chamber-specific heart cells. Then, they created a model that simulates the most common type of irregular heartbeat, atrial fibrillation, to study the effect of relevant drugs in preventing or stopping the arrhythmia after it has begun.
Prof. Gepstein received his bachelor’s degree in medical sciences (summa cum laude), his M.D. (summa cum laude), and his Ph.D. from the Technion Faculty of Medicine. He was trained in both internal medicine and cardiology at the Rambam Medical Center.
“Stay positive,” we’re told when suffering from an illness. It’s easy to dismiss such comments as platitudes from well-meaning friends. But Technion scientists have demonstrated that activation of the brain’s reward system can boost recovery from a heart attack. Establishing the connection between the two can potentially lead to therapeutic avenues for intervention. “It’s time that both researchers and clinicians take the link between psychology and physiology seriously,” said Technion Associate Professor Asya Rolls, a psychoneuroimmunologist and pioneer in mind-body interactions. Scientists have previously shown that the emotional state can influence the course of disease following a heart attack. But…
Pictured Above / (L-R) Prof. Rafi Beyar, Prof. Lior Gepstein, Technion President Prof. Uri Sivan, and Dr. Joachim Behar The Technion and Rambam Hospital are setting up a new joint Technion-Rambam Center for Artificial Intelligence in Healthcare (CAIH) that will signal a revolution in medical decision-making. The CAIH, the first joint academic-hospital AI center in Israel and one of the first in the world, will develop advanced artificial intelligence systems to analyze a patient’s condition. The center will focus on developing tools that will help physicians select, in real time, the most appropriate and accurate medical treatment for a patient….
For Steve Berger, supporting the Technion is more than philanthropy. It’s a deeply personal commitment to strengthening Israel and investing in the people who will shape its future.A longtime donor and dedicated ATS Board leader, Steve has spent years championing the Technion and its extraordinary students. Together with his wife, Ilene, he established the Berger […]
Stay on top of the latest breaking scientific discoveries from Israel and the Technion. Subscribe to the ATS newsletter.